Literature DB >> 1512539

Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

P Biswas1, G Poli, A L Kinter, J S Justement, S K Stanley, W J Maury, P Bressler, J M Orenstein, A S Fauci.   

Abstract

Interferon gamma (IFN-gamma), a lymphokine that exerts multiple immunoregulatory effects, has been found to be elevated in the plasma, cerebrospinal fluid, and lymph nodes of human immunodeficiency virus (HIV)-infected individuals and has shown variable effects on HIV replication in acutely infected cells. In the present study, we have demonstrated that IFN-gamma is a potent modulator of HIV expression in persistently infected U1 promonocytic cells in which virus production is characterized by a constitutive state of relative latency. Direct stimulation of U1 cells with IFN-gamma (10-1,000 U/ml) activated HIV expression, as measured by reverse transcriptase (RT) activity in the culture supernatant and increased levels of cell-associated viral protein and mRNAs. These effects on virus expression were not accounted for by the induction of endogenous TNF-alpha secretion, as previously described in U1 cells stimulated with phorbol myristate acetate (PMA). At the ultrastructural level, the stimulatory activity of IFN-gamma was correlated with HIV particle production in intracytoplasmic vacuoles along with the differentiation of U1 into macrophage-like cells. Furthermore, costimulation of U1 cells with IFN-gamma and PMA significantly increased the accumulation of vacuole-associated HIV concomitant with decreasing membrane-associated particles and RT activity production, as compared with cells stimulated with PMA alone. No evidence of spontaneous secretion of intracellular vacuole-associated virus was obtained by kinetic analysis of the RT activity released in the supernatants throughout the culture period unless cells were deliberately disrupted. These findings suggest that vacuole-associated virions likely represent a relatively stable intracellular reservoir of HIV, as previously described in primary macrophages infected in vitro or in infected macrophages in the brains of patients with acquired immune deficiency syndrome. The reduced levels of RT activity observed in the culture supernatants of U1 cells stimulated with PMA in the presence of IFN-gamma were not indicative of a suppressive effect of IFN-gamma on PMA-induced expression of HIV proteins and mRNAs, either directly or mediated by the release of IFN-alpha/beta. This study suggests that IFN-gamma may play an important role as an inducer of HIV expression in infected mononuclear phagocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512539      PMCID: PMC2119360          DOI: 10.1084/jem.176.3.739

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Cytokines alter production of HIV-1 from primary mononuclear phagocytes.

Authors:  Y Koyanagi; W A O'Brien; J Q Zhao; D W Golde; J C Gasson; I S Chen
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

2.  Effects of inflammatory cytokines and phorbol esters on the adhesion of U937 cells, a human monocyte-like cell line, to endothelial cell monolayers and extracellular matrix proteins.

Authors:  D E Cavender; D Edelbaum; L Welkovich
Journal:  J Leukoc Biol       Date:  1991-06       Impact factor: 4.962

Review 3.  Immunopathogenesis of HIV infection.

Authors:  Z F Rosenberg; A S Fauci
Journal:  FASEB J       Date:  1991-07       Impact factor: 5.191

4.  Gamma interferon augments functional and phenotypic characteristics of vitamin D3-induced monocytoid differentiation in the U937 human leukaemic cell line.

Authors:  S M Kelsey; H L Makin; M G Macey; A C Newland
Journal:  Leuk Res       Date:  1990       Impact factor: 3.156

5.  Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.

Authors:  J M Orenstein; M S Meltzer; T Phipps; H E Gendelman
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

6.  Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease.

Authors:  D E Griffin; J C McArthur; D R Cornblath
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

7.  Phorbol ester-induced differentiation of U937 cells enhances attachment to fibronectin and distinctly modulates the alpha 5 beta 1 and alpha 4 beta 1 fibronectin receptors.

Authors:  O C Ferreira; J E Valinsky; K Sheridan; E A Wayner; C Bianco; A Garcia-Pardo
Journal:  Exp Cell Res       Date:  1991-03       Impact factor: 3.905

8.  Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.

Authors:  H W Murray; J K Hillman; B Y Rubin; C D Kelly; J L Jacobs; L W Tyler; D M Donelly; S M Carriero; J H Godbold; R B Roberts
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

9.  In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma.

Authors:  G H Wong; J F Krowka; D P Stites; D V Goeddel
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

10.  Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.

Authors:  A H Rook; J J Hooks; G V Quinnan; H C Lane; J F Manischewitz; A M Macher; H Masur; A S Fauci; J Y Djeu
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  50 in total

1.  Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.

Authors:  Andrés Finzi; Alexandre Brunet; Yong Xiao; Jacques Thibodeau; Eric A Cohen
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Macrophages archive HIV-1 virions for dissemination in trans.

Authors:  Natalia Sharova; Catherine Swingler; Mark Sharkey; Mario Stevenson
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

3.  Roles for endocytosis in lentiviral replication.

Authors:  M Marsh; A Pelchen-Matthews; J A Hoxie
Journal:  Trends Cell Biol       Date:  1997-01       Impact factor: 20.808

4.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

5.  Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

Authors:  L Al-Harthi; K A Roebuck; A Landay
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

6.  Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.

Authors:  Olaf Kutsch; Etty N Benveniste; George M Shaw; David N Levy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

Authors:  R J Shattock; J S Friedland; G E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Authors:  C Jassoy; T Harrer; T Rosenthal; B A Navia; J Worth; R P Johnson; B D Walker
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells.

Authors:  A Vyakarnam; P M Matear; S J Martin; M Wagstaff
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

10.  Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis.

Authors:  J M Fakruddin; J Laurence
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.